Kevin Ballinger is an independent director and medtech executive currently serving as a board member for Bio X Cell, CVRx | Barostim, Zeus, and Shockwave Medical. They held the position of Chief Executive Officer at Aldevron from 2020 to 2023 and were EVP and Global President of Interventional Cardiology at Boston Scientific from 2011 to 2020. Kevin's educational background includes a Bachelor's Degree in Mechanical Engineering from Michigan Technological University and a Master of Business Administration (M.B.A.) from the University of Minnesota - Carlson School of Management, both of which they are pursuing concurrently.
This person is not in the org chart
This person is not in any teams
This person is not in any offices